- Conditions
- Vitiligo
- Interventions
- Apremilast, NB-UVB phototherapy
- Drug · Procedure
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 23 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- New York, New York
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–12
of 12
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Vitiligo
- Interventions
- Upadacitinib, Placebo, NB-UVB (narrow-band ultraviolet B) Phototherapy
- Drug · Other
- Lead sponsor
- AbbVie
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 614 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2028
- U.S. locations
- 46
- States / cities
- Glendale, Arizona • Phoenix, Arizona • Encino, California + 35 more
- Conditions
- Psoriasis
- Interventions
- Levia Narrow Band UVB, Levia sham/visible-light source
- Device
- Lead sponsor
- Tufts Medical Center
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 21 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Vitiligo
- Interventions
- Ruxolitinib 1.5% cream, NB-UVB phototherapy
- Drug · Device
- Lead sponsor
- Incyte Corporation
- Industry
- Eligibility
- 12 Years to 99 Years
- Enrollment
- 55 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2022 – 2023
- U.S. locations
- 11
- States / cities
- Fountain Valley, California • Sacramento, California • Sunnyvale, California + 8 more
- Conditions
- Oral Chronic Graft-versus-host Disease
- Interventions
- Narrow-Band UVB Phototherapy
- Procedure
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 4 Years and older
- Enrollment
- 11 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2008
- U.S. locations
- 2
- States / cities
- Boston, Massachusetts
- Conditions
- Vitiligo
- Interventions
- Afamelanotide, Narrow-Band UVB Light Treatment
- Drug · Procedure
- Lead sponsor
- Clinuvel Pharmaceuticals Limited
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 56 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 2
- States / cities
- Detroit, Michigan • New York, New York
- Conditions
- Psoriasis
- Interventions
- Daclizumab, NB-UVB
- Drug · Device
- Lead sponsor
- Rockefeller University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1997 – 2008
- U.S. locations
- 3
- States / cities
- New York, New York
- Conditions
- Psoriasis
- Interventions
- Narrow band (310-312 nm) ultraviolet light B phototherapy, etanercept
- Procedure · Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 30 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Vitiligo, Pigmentation, Dyschromia
- Interventions
- narrow-band ultraviolet B phototherapy
- Device
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 2 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2016
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
- Conditions
- Covid19, Corona Virus Infection, Autoimmune Diseases, Coagulation Disorder, Blood
- Interventions
- Narrow Band ultraviolet B-Band Light, non Narrow Band ultraviolet B-Band Light
- Device
- Lead sponsor
- Cytokind, Inc.
- Industry
- Eligibility
- 50 Years to 110 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 1
- States / cities
- New Orleans, Louisiana
- Conditions
- Vitiligo
- Interventions
- Afamelanotide and NB-UVB Light, NB-UVB Light
- Drug · Procedure
- Lead sponsor
- Clinuvel, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 25
- States / cities
- Birmingham, Alabama • Fresno, California • Los Angeles, California + 22 more
- Conditions
- Atopic Dermatitis
- Interventions
- Narrow band UVB treatment (NB-UVB)
- Other
- Lead sponsor
- Rockefeller University
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 6 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2020
- U.S. locations
- 1
- States / cities
- New York, New York